Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kos Pharmaceuticals Inc (KOSP) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Kos Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1018952.
Total stock buying since 2005: $0.
Total stock sales since 2005: $10,496,665.
Total stock option exercises since 2005: $1,890,841.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2006 | 0 | $0 | 83,250 | $4,402,956 | 83,250 | $1,890,841 |
| 2005 | 0 | $0 | 88,352 | $6,093,709 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2006-11 | 0 | $0 | 12,500 | $961,875 | 12,500 | $444,750 |
| 2006-03 | 0 | $0 | 65,750 | $3,191,081 | 65,750 | $1,348,591 |
| 2006-02 | 0 | $0 | 5,000 | $250,000 | 5,000 | $97,500 |
| 2005-12 | 0 | $0 | 39,800 | $2,822,301 | 0 | $0 |
| 2005-08 | 0 | $0 | 22,327 | $1,583,509 | 0 | $0 |
| 2005-07 | 0 | $0 | 8,309 | $622,875 | 0 | $0 |
| 2005-06 | 0 | $0 | 10,766 | $681,591 | 0 | $0 |
| 2005-05 | 0 | $0 | 7,150 | $383,433 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-11-06 | Rosskamp Ralf (EVP, Research and Development) | Sale | 12,500 | 76.95 | 961,875 |
| 2006-11-06 | Rosskamp Ralf (EVP, Research and Development) | Option Ex | 12,500 | 35.58 | 444,750 |
| 2006-03-16 | Rodriguez Juan F (SVP, Controller & Corp. Admin.) | Sale | 7,000 | 50.80 | 355,600 |
| 2006-03-16 | Rodriguez Juan F (SVP, Controller & Corp. Admin.) | Option Ex | 7,000 | 16.23 | 113,645 |
| 2006-03-14 | Baldini Robert E (Director) | Sale | 7,500 | 48.80 | 366,000 |
| 2006-03-14 | Baldini Robert E (Director) | Option Ex | 7,500 | 22.55 | 169,125 |
| 2006-03-13 | Baldini Robert E (Director) | Sale | 2,500 | 49.40 | 123,500 |
| 2006-03-13 | Baldini Robert E (Director) | Option Ex | 2,500 | 22.55 | 56,375 |
| 2006-03-13 | Mcgovern Mark E (EVP, Chief Medical Officer) | Sale | 28,750 | 49.00 | 1,408,750 |
| 2006-03-13 | Mcgovern Mark E (EVP, Chief Medical Officer) | Option Ex | 28,750 | 21.02 | 604,468 |
| 2006-03-10 | King Richard (EVP, Commercial Operations) | Sale | 5,000 | 50.00 | 250,000 |
| 2006-03-10 | King Richard (EVP, Commercial Operations) | Option Ex | 5,000 | 19.50 | 97,500 |
| 2006-03-09 | Baldini Robert E (Director) | Sale | 2,500 | 47.50 | 118,750 |
| 2006-03-07 | Baldini Robert E (Director) | Sale | 7,322 | 45.81 | 335,420 |
| 2006-03-07 | Baldini Robert E (Director) | Option Ex | 9,822 | 21.02 | 206,507 |
| 2006-03-06 | Baldini Robert E (Director) | Sale | 5,178 | 45.01 | 233,061 |
| 2006-03-06 | Baldini Robert E (Director) | Option Ex | 5,178 | 19.50 | 100,971 |
| 2006-02-16 | King Richard (EVP, Commercial Operations) | Sale | 5,000 | 50.00 | 250,000 |
| 2006-02-16 | King Richard (EVP, Commercial Operations) | Option Ex | 5,000 | 19.50 | 97,500 |
| 2005-12-14 | Whittemore Frederick B (Director) | Sale | 17,600 | 70.48 | 1,240,377 |
| 2005-12-08 | Whittemore Frederick B (Director) | Sale | 18,000 | 71.31 | 1,281,545 |
| 2005-08-16 | Adams Adrian (CEO) | Sale | 13,818 | 70.87 | 979,452 |
| 2005-08-01 | King Richard (EVP, Commerical Oper) | Sale | 3,000 | 71.34 | 214,020 |
| 2005-07-19 | Adams Adrian (CEO) | Sale | 8,309 | 74.96 | 622,875 |
| 2005-06-21 | Adams Adrian (CEO) | Sale | 7,150 | 66.18 | 473,201 |
| 2005-06-14 | Baldini Robert E (Director) | Sale | 3,616 | 57.63 | 208,390 |
| 2005-05-17 | Adams Adrian (CEO) | Sale | 7,150 | 53.63 | 383,433 |
Insider trading activities including stock purchases, stock sales, and option exercises of KOSP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kos Pharmaceuticals Inc (symbol KOSP, CIK number 1018952) see the Securities and Exchange Commission (SEC) website.